25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

InBody Co.Ltd
Buy, Hold or Sell?

Let's analyze Inbody together

I guess you are interested in InBody Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of InBody Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about InBody Co.Ltd

I send you an email if I find something interesting about InBody Co.Ltd.

1. Quick Overview

1.1. Quick analysis of Inbody (30 sec.)










1.2. What can you expect buying and holding a share of Inbody? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
72.5%

What is your share worth?

Current worth
₩19,565.67
Expected worth in 1 year
₩22,121.63
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
₩2,555.96
Return On Investment
11.5%

For what price can you sell your share?

Current Price per Share
₩22,200.00
Expected price per share
₩20,462 - ₩23,150
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Inbody (5 min.)




Live pricePrice per Share (EOD)
₩22,200.00

2.2. Growth of Inbody (5 min.)




Is Inbody growing?

Current yearPrevious yearGrowGrow %
How rich?$184.6m$153.8m$23.1m13.1%

How much money is Inbody making?

Current yearPrevious yearGrowGrow %
Making money$6.3m$5.6m$682.4k10.7%
Net Profit Margin19.7%19.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Inbody (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Inbody?

Welcome investor! Inbody's management wants to use your money to grow the business. In return you get a share of Inbody.

First you should know what it really means to hold a share of Inbody. And how you can make/lose money.

Speculation

The Price per Share of Inbody is ₩22,200. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inbody.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inbody, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩19,565.67. Based on the TTM, the Book Value Change Per Share is ₩638.99 per quarter. Based on the YOY, the Book Value Change Per Share is ₩530.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inbody.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.430.0%0.470.0%0.420.0%0.380.0%0.310.0%
Usd Book Value Change Per Share0.470.0%0.450.0%0.370.0%0.340.0%0.270.0%
Usd Dividend Per Share0.000.0%0.000.0%0.120.0%0.090.0%0.070.0%
Usd Total Gains Per Share0.470.0%0.450.0%0.490.0%0.430.0%0.340.0%
Usd Price Per Share18.20-18.62-17.12-16.33-20.16-
Price to Earnings Ratio10.56-10.20-10.50-17.24-24.96-
Price-to-Total Gains Ratio39.03-49.00-38.21-33.35-66.55-
Price to Book Ratio1.33-1.42-1.49-1.68-3.54-
Price-to-Total Gains Ratio39.03-49.00-38.21-33.35-66.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.54
Number of shares64
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.09
Usd Book Value Change Per Share0.450.34
Usd Total Gains Per Share0.450.43
Gains per Quarter (64 shares)28.6327.37
Gains per Year (64 shares)114.51109.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10115105228899
2022922044175208
3034433566263317
4045845088350426
50573565110438535
60687680132525644
70802795154613753
80916910176700862
9010311025198788971
100114511402208751080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%46.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%38.02.00.095.0%44.02.00.095.7%
Dividend per Share0.00.04.00.0%7.00.05.058.3%15.00.05.075.0%29.00.011.072.5%32.00.014.069.6%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%38.02.00.095.0%44.02.00.095.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of InBody Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--666.154638.991+4%529.999+26%488.396+36%384.394+73%
Book Value Per Share--19565.67018757.160+4%16302.828+20%14169.206+38%10539.010+86%
Current Ratio--6.5366.773-4%6.733-3%6.5380%4.983+31%
Debt To Asset Ratio--0.1110.113-1%0.116-4%0.110+1%0.099+12%
Debt To Equity Ratio--0.1260.129-2%0.131-4%0.124+1%0.111+13%
Dividend Per Share----0%169.084-100%122.564-100%94.920-100%
Enterprise Value--317490405000.000326217519670.000-3%390368278207.500-19%343355689221.000-8%398073038363.500-20%
Eps--615.704675.459-9%603.149+2%546.631+13%437.433+41%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--1.5801.765-11%2.355-33%2.397-34%4.073-61%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap299313720000.000-17%350547600000.000358637160000.000-2%329649570000.000+6%314549058000.000+11%388252601875.000-10%
Net Profit Margin--0.1650.197-16%0.197-16%0.197-16%0.202-18%
Operating Margin----0%0.048-100%0.135-100%0.125-100%
Operating Ratio--0.4420.866-49%0.535-17%0.517-15%0.563-22%
Pb Ratio1.135-17%1.3291.418-6%1.493-11%1.682-21%3.539-62%
Pe Ratio9.014-17%10.55710.204+3%10.501+1%17.245-39%24.962-58%
Price Per Share22200.000-17%26000.00026600.000-2%24450.000+6%23330.000+11%28796.250-10%
Price To Free Cash Flow Ratio---10.858-100%9.313-100%18.102-100%25.230-100%
Price To Total Gains Ratio33.326-17%39.03049.001-20%38.209+2%33.347+17%66.554-41%
Quick Ratio---3.140-100%8.386-100%6.622-100%4.762-100%
Return On Assets--0.0280.032-13%0.033-15%0.034-18%0.039-28%
Return On Equity--0.0320.036-13%0.037-15%0.038-18%0.043-27%
Total Gains Per Share--666.154638.991+4%699.084-5%610.960+9%479.313+39%
Usd Book Value--184657272.100177026700.128+4%153863153.479+20%133726415.920+38%99465871.715+86%
Usd Book Value Change Per Share--0.4660.447+4%0.371+26%0.342+36%0.269+73%
Usd Book Value Per Share--13.69613.130+4%11.412+20%9.918+38%7.377+86%
Usd Dividend Per Share----0%0.118-100%0.086-100%0.066-100%
Usd Enterprise Value--222243283.500228352263.769-3%273257794.745-19%240348982.455-8%278651126.854-20%
Usd Eps--0.4310.473-9%0.422+2%0.383+13%0.306+41%
Usd Free Cash Flow---3377484.325-100%6157949.788-100%4448031.272-100%3670650.841-100%
Usd Market Cap209519604.000-17%245383320.000251046012.000-2%230754699.000+6%220184340.600+11%271776821.313-10%
Usd Price Per Share15.540-17%18.20018.620-2%17.115+6%16.331+11%20.157-10%
Usd Profit--5810903.0006374859.517-9%5692410.798+2%5159008.851+13%4128451.824+41%
Usd Revenue--35170156.70032433866.005+8%28991046.565+21%25652090.501+37%20249203.506+74%
Usd Total Gains Per Share--0.4660.447+4%0.489-5%0.428+9%0.336+39%
 EOD+3 -4MRQTTM+14 -17YOY+18 -165Y+19 -1510Y+17 -17

3.3 Fundamental Score

Let's check the fundamental score of InBody Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.014
Price to Book Ratio (EOD)Between0-11.135
Net Profit Margin (MRQ)Greater than00.165
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than16.536
Debt to Asset Ratio (MRQ)Less than10.111
Debt to Equity Ratio (MRQ)Less than10.126
Return on Equity (MRQ)Greater than0.150.032
Return on Assets (MRQ)Greater than0.050.028
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of InBody Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.042
Ma 20Greater thanMa 5022,347.500
Ma 50Greater thanMa 10022,973.000
Ma 100Greater thanMa 20023,410.500
OpenGreater thanClose22,550.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About InBody Co.Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 16:19:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Inbody earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Inbody to the Healthcare Equipment & Supplies industry mean.
  • A Net Profit Margin of 16.5% means that ₩0.17 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of InBody Co.Ltd:

  • The MRQ is 16.5%. The company is making a huge profit. +2
  • The TTM is 19.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.5%TTM19.7%-3.2%
TTM19.7%YOY19.7%+0.0%
TTM19.7%5Y19.7%+0.0%
5Y19.7%10Y20.2%-0.5%
4.3.1.2. Return on Assets

Shows how efficient Inbody is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Inbody to the Healthcare Equipment & Supplies industry mean.
  • 2.8% Return on Assets means that Inbody generated ₩0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of InBody Co.Ltd:

  • The MRQ is 2.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.8%TTM3.2%-0.4%
TTM3.2%YOY3.3%-0.1%
TTM3.2%5Y3.4%-0.2%
5Y3.4%10Y3.9%-0.5%
4.3.1.3. Return on Equity

Shows how efficient Inbody is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Inbody to the Healthcare Equipment & Supplies industry mean.
  • 3.2% Return on Equity means Inbody generated ₩0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of InBody Co.Ltd:

  • The MRQ is 3.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.2%TTM3.6%-0.5%
TTM3.6%YOY3.7%-0.1%
TTM3.6%5Y3.8%-0.2%
5Y3.8%10Y4.3%-0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of InBody Co.Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Inbody is operating .

  • Measures how much profit Inbody makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Inbody to the Healthcare Equipment & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of InBody Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY4.8%-4.8%
TTM-5Y13.5%-13.5%
5Y13.5%10Y12.5%+1.0%
4.3.2.2. Operating Ratio

Measures how efficient Inbody is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Healthcare Equipment & Supplies industry mean).
  • An Operation Ratio of 0.44 means that the operating costs are ₩0.44 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of InBody Co.Ltd:

  • The MRQ is 0.442. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.866. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.442TTM0.866-0.424
TTM0.866YOY0.535+0.331
TTM0.8665Y0.517+0.349
5Y0.51710Y0.563-0.046
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of InBody Co.Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Inbody is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Healthcare Equipment & Supplies industry mean).
  • A Current Ratio of 6.54 means the company has ₩6.54 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of InBody Co.Ltd:

  • The MRQ is 6.536. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.773. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.536TTM6.773-0.237
TTM6.773YOY6.733+0.040
TTM6.7735Y6.538+0.235
5Y6.53810Y4.983+1.555
4.4.3.2. Quick Ratio

Measures if Inbody is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Inbody to the Healthcare Equipment & Supplies industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of InBody Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.140-3.140
TTM3.140YOY8.386-5.246
TTM3.1405Y6.622-3.482
5Y6.62210Y4.762+1.860
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of InBody Co.Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Inbody assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Inbody to Healthcare Equipment & Supplies industry mean.
  • A Debt to Asset Ratio of 0.11 means that Inbody assets are financed with 11.1% credit (debt) and the remaining percentage (100% - 11.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of InBody Co.Ltd:

  • The MRQ is 0.111. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.113. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.111TTM0.113-0.002
TTM0.113YOY0.116-0.003
TTM0.1135Y0.110+0.003
5Y0.11010Y0.099+0.011
4.5.4.2. Debt to Equity Ratio

Measures if Inbody is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Inbody to the Healthcare Equipment & Supplies industry mean.
  • A Debt to Equity ratio of 12.6% means that company has ₩0.13 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of InBody Co.Ltd:

  • The MRQ is 0.126. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.129. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.126TTM0.129-0.003
TTM0.129YOY0.131-0.003
TTM0.1295Y0.124+0.004
5Y0.12410Y0.111+0.013
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Inbody generates.

  • Above 15 is considered overpriced but always compare Inbody to the Healthcare Equipment & Supplies industry mean.
  • A PE ratio of 10.56 means the investor is paying ₩10.56 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of InBody Co.Ltd:

  • The EOD is 9.014. Based on the earnings, the company is underpriced. +1
  • The MRQ is 10.557. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.204. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.014MRQ10.557-1.543
MRQ10.557TTM10.204+0.353
TTM10.204YOY10.501-0.297
TTM10.2045Y17.245-7.041
5Y17.24510Y24.962-7.717
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of InBody Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.858-10.858
TTM10.858YOY9.313+1.545
TTM10.8585Y18.102-7.245
5Y18.10210Y25.230-7.128
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Inbody is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Healthcare Equipment & Supplies industry mean).
  • A PB ratio of 1.33 means the investor is paying ₩1.33 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of InBody Co.Ltd:

  • The EOD is 1.135. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.329. Based on the equity, the company is underpriced. +1
  • The TTM is 1.418. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.135MRQ1.329-0.194
MRQ1.329TTM1.418-0.089
TTM1.418YOY1.493-0.074
TTM1.4185Y1.682-0.264
5Y1.68210Y3.539-1.857
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets296,853,298
Total Liabilities33,057,195
Total Stockholder Equity262,588,630
 As reported
Total Liabilities 33,057,195
Total Stockholder Equity+ 262,588,630
Total Assets = 296,853,298

Assets

Total Assets296,853,298
Total Current Assets166,923,750
Long-term Assets129,929,548
Total Current Assets
Total Current Assets  (as reported)166,923,750
Total Current Assets  (calculated)0
+/- 166,923,750
Long-term Assets
Long-term Assets  (as reported)129,929,548
Long-term Assets  (calculated)0
+/- 129,929,548

Liabilities & Shareholders' Equity

Total Current Liabilities25,540,253
Long-term Liabilities7,516,941
Total Stockholder Equity262,588,630
Total Current Liabilities
Total Current Liabilities  (as reported)25,540,253
Total Current Liabilities  (calculated)0
+/- 25,540,253
Long-term Liabilities
Long-term Liabilities  (as reported)7,516,941
Long-term Liabilities  (calculated)0
+/- 7,516,941
Total Stockholder Equity
Total Stockholder Equity (as reported)262,588,630
Total Stockholder Equity (calculated)0
+/- 262,588,630
Other
Common Stock Shares Outstanding 13,027
Net Invested Capital 262,588,630
Net Working Capital 141,383,497



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
51,035,683
52,434,186
53,909,011
53,672,982
58,614,397
61,001,382
63,385,858
63,171,082
74,269,895
73,429,038
79,256,818
82,529,853
91,707,402
93,156,018
93,237,387
97,059,397
97,254,629
102,430,767
110,987,256
112,024,745
118,745,248
138,215,538
134,710,240
131,686,126
142,580,826
146,486,400
153,456,163
154,903,556
161,694,579
153,708,056
161,953,611
166,150,336
179,249,823
188,574,150
197,234,675
203,760,043
217,176,648
225,121,734
237,614,940
242,665,327
255,700,268
258,836,010
271,718,578
274,456,138
298,231,691
296,853,298
296,853,298298,231,691274,456,138271,718,578258,836,010255,700,268242,665,327237,614,940225,121,734217,176,648203,760,043197,234,675188,574,150179,249,823166,150,336161,953,611153,708,056161,694,579154,903,556153,456,163146,486,400142,580,826131,686,126134,710,240138,215,538118,745,248112,024,745110,987,256102,430,76797,254,62997,059,39793,237,38793,156,01891,707,40282,529,85379,256,81873,429,03874,269,89563,171,08263,385,85861,001,38258,614,39753,672,98253,909,01152,434,18651,035,683
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65,997,169
74,142,194
75,126,019
81,150,352
64,945,439
59,274,159
55,513,711
66,126,271
65,963,448
73,461,486
74,044,209
81,021,378
73,126,396
81,066,324
84,350,949
97,790,044
104,901,902
111,626,749
110,109,706
120,684,712
125,836,618
137,656,994
135,489,178
148,598,419
147,608,577
151,694,470
148,963,799
171,586,452
166,923,750
166,923,750171,586,452148,963,799151,694,470147,608,577148,598,419135,489,178137,656,994125,836,618120,684,712110,109,706111,626,749104,901,90297,790,04484,350,94981,066,32473,126,39681,021,37874,044,20973,461,48665,963,44866,126,27155,513,71159,274,15964,945,43981,150,35275,126,01974,142,19465,997,16900000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,829,510
11,863,453
11,243,192
8,518,116
8,126,489
10,483,192
9,627,293
13,602,649
16,801,736
17,891,168
14,420,279
10,291,968
17,456,013
19,713,874
16,980,847
18,749,342
16,781,592
14,899,007
0
0
0
0
21,557,845
22,131,075
20,810,595
24,060,915
22,285,959
27,428,966
0
027,428,96622,285,95924,060,91520,810,59522,131,07521,557,845000014,899,00716,781,59218,749,34216,980,84719,713,87417,456,01310,291,96814,420,27917,891,16816,801,73613,602,6499,627,29310,483,1928,126,4898,518,11611,243,19211,863,4539,829,51000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,306,000
36,409,500
39,135,000
40,472,000
23,637,000
16,440,000
15,843,520
16,885,178
15,259,220
20,256,847
0
0
0
29,111,511
40,509,769
46,612,888
52,626,278
58,757,234
52,867,027
54,980,423
53,130,448
61,504,774
64,988,375
72,329,848
75,454,100
69,999,820
76,681,443
77,378,570
0
077,378,57076,681,44369,999,82075,454,10072,329,84864,988,37561,504,77453,130,44854,980,42352,867,02758,757,23452,626,27846,612,88840,509,76929,111,51100020,256,84715,259,22016,885,17815,843,52016,440,00023,637,00040,472,00039,135,00036,409,50034,306,00000000000000000000
       Net Receivables 
4,394,591
4,804,955
4,265,604
4,106,362
5,131,178
4,537,041
4,781,431
4,208,492
12,054,865
6,698,978
8,086,664
11,061,401
15,947,079
9,730,114
11,548,656
11,662,674
10,105,763
10,865,082
13,810,421
12,807,617
11,831,406
13,797,247
11,979,079
12,843,239
17,656,639
14,601,048
11,238,113
10,555,259
12,131,261
9,270,977
11,711,238
8,760,434
12,367,855
13,569,516
72,892,996
17,398,141
20,453,672
23,079,436
22,670,059
16,485,009
20,208,560
17,478,931
20,895,824
14,961,008
29,172,852
0
029,172,85214,961,00820,895,82417,478,93120,208,56016,485,00922,670,05923,079,43620,453,67217,398,14172,892,99613,569,51612,367,8558,760,43411,711,2389,270,97712,131,26110,555,25911,238,11314,601,04817,656,63912,843,23911,979,07913,797,24711,831,40612,807,61713,810,42110,865,08210,105,76311,662,67411,548,6569,730,11415,947,07911,061,4018,086,6646,698,97812,054,8654,208,4924,781,4314,537,0415,131,1784,106,3624,265,6044,804,9554,394,591
       Other Current Assets 
1,550,560
1,373,188
1,295,059
1,348,491
1,205,780
1,768,622
1,627,000
1,236,139
2,228,230
1,167,859
1,636,936
1,332,035
1,225,465
655,468
826,135
687,875
1,143,095
1,679,955
1,631,177
1,335,006
5,876,888
1,478,463
2,131,446
527,315
585,110
980,295
244,056
961,536
1,228,492
1,592,511
1,614,212
1,167,370
2,255,473
3,470,052
2,574,864
2,387,753
2,861,085
2,964,661
3,645,516
939,343
1,071,010
1,040,259
1,037,228
971,619
1,073,758
0
01,073,758971,6191,037,2281,040,2591,071,010939,3433,645,5162,964,6612,861,0852,387,7532,574,8643,470,0522,255,4731,167,3701,614,2121,592,5111,228,492961,536244,056980,295585,110527,3152,131,4461,478,4635,876,8881,335,0061,631,1771,679,9551,143,095687,875826,135655,4681,225,4651,332,0351,636,9361,167,8592,228,2301,236,1391,627,0001,768,6221,205,7801,348,4911,295,0591,373,1881,550,560
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
107,176,149
107,101,849
111,227,434
120,024,108
125,492,339
126,645,239
129,929,548
129,929,548126,645,239125,492,339120,024,108111,227,434107,101,849107,176,149000000000000000000000000000000000000000
       Property Plant Equipment 
16,431,586
16,534,133
16,388,714
16,389,996
16,135,064
16,035,604
15,805,529
16,747,295
16,614,405
17,252,903
19,253,394
22,961,897
22,295,400
25,347,344
26,246,274
27,933,108
29,431,101
31,571,865
31,934,748
31,844,677
32,282,153
67,954,064
70,215,465
71,110,490
71,864,199
76,380,308
76,173,301
74,638,447
74,461,507
73,991,133
74,360,551
69,277,643
67,420,458
67,401,685
66,910,106
75,835,165
75,867,877
76,409,699
76,442,223
81,730,967
81,742,973
82,636,005
83,446,177
85,908,704
87,480,995
0
087,480,99585,908,70483,446,17782,636,00581,742,97381,730,96776,442,22376,409,69975,867,87775,835,16566,910,10667,401,68567,420,45869,277,64374,360,55173,991,13374,461,50774,638,44776,173,30176,380,30871,864,19971,110,49070,215,46567,954,06432,282,15331,844,67731,934,74831,571,86529,431,10127,933,10826,246,27425,347,34422,295,40022,961,89719,253,39417,252,90316,614,40516,747,29515,805,52916,035,60416,135,06416,389,99616,388,71416,534,13316,431,586
       Goodwill 
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
0
0
0
177,074
0
0
0
177,074
0
0
0
177,074
177,074
0
0
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
177,074
0
0177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,07400177,074177,074000177,074000177,074000177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074177,074
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
710,979
712,002
741,116
742,429
751,539
952,692
984,786
986,256
982,084
977,355
2,496,939
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002,496,939977,355982,084986,256984,786952,692751,539742,429741,116712,002710,97900000000000000000
       Intangible Assets 
2,356,529
1,456,644
2,335,143
1,390,660
2,211,977
1,379,638
2,131,245
1,363,234
1,446,278
1,484,028
1,486,893
1,030,587
1,041,328
1,674,015
1,694,216
1,357,345
1,602,030
1,502,146
1,600,971
1,334,490
1,406,626
1,329,189
1,220,474
911,855
1,093,108
917,687
814,093
580,657
605,715
770,556
735,609
550,406
808,337
921,083
947,381
1,145,656
1,378,775
1,488,943
1,509,851
1,499,332
1,198,918
1,142,192
1,111,686
1,044,538
1,094,666
0
01,094,6661,044,5381,111,6861,142,1921,198,9181,499,3321,509,8511,488,9431,378,7751,145,656947,381921,083808,337550,406735,609770,556605,715580,657814,093917,6871,093,108911,8551,220,4741,329,1891,406,6261,334,4901,600,9711,502,1461,602,0301,357,3451,694,2161,674,0151,041,3281,030,5871,486,8931,484,0281,446,2781,363,2342,131,2451,379,6382,211,9771,390,6602,335,1431,456,6442,356,529
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0110000000000000000000000000000000000000000000
> Total Liabilities 
3,386,467
3,105,742
3,421,491
2,114,494
4,365,260
4,510,369
4,640,219
3,560,632
11,666,502
6,943,151
6,924,762
6,180,196
11,551,456
8,279,703
5,630,471
4,726,767
7,328,616
7,269,730
9,875,727
5,508,522
9,557,218
22,903,877
14,014,317
7,153,672
15,212,319
14,387,308
16,453,448
15,211,276
19,004,339
15,075,100
17,353,949
16,085,479
20,544,899
21,239,440
21,924,138
20,025,245
25,740,730
24,369,754
25,903,858
27,405,128
32,788,588
29,500,951
28,583,030
24,621,262
43,417,074
33,057,195
33,057,19543,417,07424,621,26228,583,03029,500,95132,788,58827,405,12825,903,85824,369,75425,740,73020,025,24521,924,13821,239,44020,544,89916,085,47917,353,94915,075,10019,004,33915,211,27616,453,44814,387,30815,212,3197,153,67214,014,31722,903,8779,557,2185,508,5229,875,7277,269,7307,328,6164,726,7675,630,4718,279,70311,551,4566,180,1966,924,7626,943,15111,666,5023,560,6324,640,2194,510,3694,365,2602,114,4943,421,4913,105,7423,386,467
   > Total Current Liabilities 
3,193,719
2,897,797
3,217,272
1,918,485
4,193,689
4,330,194
4,485,945
3,394,164
11,481,791
6,943,151
6,924,762
6,180,196
11,256,321
8,264,691
5,615,347
4,114,251
6,851,218
6,747,045
9,331,143
4,978,133
8,980,296
22,268,358
13,376,810
6,398,107
14,368,860
10,836,403
13,001,565
10,854,620
14,875,585
10,028,506
12,360,520
11,113,231
15,805,296
16,766,373
17,625,708
16,252,909
21,939,398
19,895,574
20,479,916
19,204,628
24,658,304
20,707,176
21,097,378
17,451,048
35,526,683
25,540,253
25,540,25335,526,68317,451,04821,097,37820,707,17624,658,30419,204,62820,479,91619,895,57421,939,39816,252,90917,625,70816,766,37315,805,29611,113,23112,360,52010,028,50614,875,58510,854,62013,001,56510,836,40314,368,8606,398,10713,376,81022,268,3588,980,2964,978,1339,331,1436,747,0456,851,2184,114,2515,615,3478,264,69111,256,3216,180,1966,924,7626,943,15111,481,7913,394,1644,485,9454,330,1944,193,6891,918,4853,217,2722,897,7973,193,719
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,220,843
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000014,220,843000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,220,843
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000014,220,843000000000000000000000
       Accounts payable 
0
63,411
0
119,652
0
680,280
0
164,509
5,330,199
855,990
1,251,325
132,541
2,241,175
24,145
355,967
384,225
965,832
911,876
2,234,593
326,614
2,134,831
1,916,534
0
192,450
4,355,505
2,470,725
1,027,910
959,906
2,261,730
1,093,291
965,104
535,203
1,755,260
3,188,946
2,538,322
1,163,367
3,445,392
2,418,912
1,898,251
26,725
1,855,788
1,805,248
2,392,039
155,795
11,447,680
0
011,447,680155,7952,392,0391,805,2481,855,78826,7251,898,2512,418,9123,445,3921,163,3672,538,3223,188,9461,755,260535,203965,1041,093,2912,261,730959,9061,027,9102,470,7254,355,505192,45001,916,5342,134,831326,6142,234,593911,876965,832384,225355,96724,1452,241,175132,5411,251,325855,9905,330,199164,5090680,2800119,652063,4110
       Other Current Liabilities 
3,193,719
2,834,386
3,217,272
1,798,833
4,193,689
3,649,914
4,485,945
3,229,655
6,151,592
6,087,161
5,673,437
6,047,655
9,015,146
8,240,546
5,259,380
3,730,026
5,885,386
5,835,169
7,096,550
4,651,519
6,845,465
5,347,317
5,801,284
5,570,510
9,493,025
5,515,088
8,319,659
9,894,714
12,613,855
5,353,489
7,354,470
7,665,265
12,050,480
9,667,484
10,599,504
11,860,947
11,657,075
14,641,232
15,709,293
1,194,968
1,745,513
2,148,993
2,651,429
1
0
0
0012,651,4292,148,9931,745,5131,194,96815,709,29314,641,23211,657,07511,860,94710,599,5049,667,48412,050,4807,665,2657,354,4705,353,48912,613,8559,894,7148,319,6595,515,0889,493,0255,570,5105,801,2845,347,3176,845,4654,651,5197,096,5505,835,1695,885,3863,730,0265,259,3808,240,5469,015,1466,047,6555,673,4376,087,1616,151,5923,229,6554,485,9453,649,9144,193,6891,798,8333,217,2722,834,3863,193,719
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,421,305
7,353,048
7,622,174
7,485,652
7,170,214
7,890,391
7,516,941
7,516,9417,890,3917,170,2147,485,6527,622,1747,353,0487,421,305000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,261,438
2,961,222
2,674,846
3,288,947
3,479,045
2,809,976
2,624,594
2,394,960
2,101,978
1,831,339
1,705,009
1,887,299
1,709,228
4,301,487
4,088,833
3,872,695
0
0
0
0
00003,872,6954,088,8334,301,4871,709,2281,887,2991,705,0091,831,3392,101,9782,394,9602,624,5942,809,9763,479,0453,288,9472,674,8462,961,2222,261,43800000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-14,220,843
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,396,819
6,224,754
6,043,887
7,020,271
6,080,293
6,982,434
0
06,982,4346,080,2937,020,2716,043,8876,224,7546,396,81900000000000000000-14,220,843000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
883,763
0
0883,76300000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
177,778
0
0
0
54,909
0
0
0
16,154
6,465
0
0
27,124
15,500
3,875
0
0
0
0
0
0
0
0
0
0
0
0
0000000000003,87515,50027,124006,46516,15400054,909000177,7780000000000000000000
> Total Stockholder Equity
47,649,216
49,328,444
50,487,519
51,558,488
54,249,137
56,491,013
58,745,639
59,584,168
62,577,111
66,452,470
72,298,320
76,317,751
80,117,013
84,833,976
87,566,159
92,298,761
89,887,635
95,120,276
101,067,801
106,476,729
108,957,318
115,114,905
120,525,157
124,386,199
127,209,294
132,006,036
137,002,715
139,692,280
142,690,240
138,632,956
144,599,662
150,064,858
158,704,924
167,334,710
175,310,537
183,734,798
191,435,918
200,751,980
211,711,082
215,260,199
222,911,680
229,335,059
241,998,511
248,765,778
253,798,657
262,588,630
262,588,630253,798,657248,765,778241,998,511229,335,059222,911,680215,260,199211,711,082200,751,980191,435,918183,734,798175,310,537167,334,710158,704,924150,064,858144,599,662138,632,956142,690,240139,692,280137,002,715132,006,036127,209,294124,386,199120,525,157115,114,905108,957,318106,476,729101,067,80195,120,27689,887,63592,298,76187,566,15984,833,97680,117,01376,317,75172,298,32066,452,47062,577,11159,584,16858,745,63956,491,01354,249,13751,558,48850,487,51949,328,44447,649,216
   Common Stock
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
6,841,891
0
0
0
0
00006,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,8916,841,891
   Retained Earnings 
40,869,666
0
43,474,639
0
47,385,243
0
52,121,826
0
0
0
0
0
0
0
0
0
0
91,259,977
97,014,678
103,245,565
105,299,542
111,328,082
117,314,416
121,298,319
125,086,511
131,772,665
136,731,125
139,970,055
143,052,580
143,455,106
149,350,802
155,625,778
163,848,711
172,187,098
179,256,493
187,835,512
195,281,677
203,911,148
213,116,005
219,045,677
225,485,795
232,531,156
244,583,985
251,860,447
256,098,238
0
0256,098,238251,860,447244,583,985232,531,156225,485,795219,045,677213,116,005203,911,148195,281,677187,835,512179,256,493172,187,098163,848,711155,625,778149,350,802143,455,106143,052,580139,970,055136,731,125131,772,665125,086,511121,298,319117,314,416111,328,082105,299,542103,245,56597,014,67891,259,977000000000052,121,826047,385,243043,474,639040,869,666
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
470,964
470,964
0
470,964
470,964
470,964
470,964
470,964
470,964
470,964
470,964
470,964
470,964
470,964
470,964
470,964
0
0
0
0
0000470,964470,964470,964470,964470,964470,964470,964470,964470,964470,964470,964470,964470,9640470,964470,96400000000000000000000000000
   Treasury Stock00000000000-12,094,398-12,094,398-12,102,557-12,102,556-12,102,557-12,102,557-7,963,442-7,107,432-7,107,432000-3,108,546-3,108,546-3,108,546-3,108,546-3,108,546-3,108,546-3,108,546-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257-255,257
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-425,027
-232,203
-1,054,161
-627,550
-498,503
-1,074,585
-939,618
-532,082
-438,535
236,724
-564,215
132,752
-113,465
-42,454
-852,237
-435,102
-151,862
754,571
599,811
854,767
1,541,358
3,295,603
996,065
2,207,428
1,585,446
0
0
0
0
00001,585,4462,207,428996,0653,295,6031,541,358854,767599,811754,571-151,862-435,102-852,237-42,454-113,465132,752-564,215236,724-438,535-532,082-939,618-1,074,585-498,503-627,550-1,054,161-232,203-425,02700000000000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue170,351,230
Cost of Revenue-37,896,369
Gross Profit132,454,860132,454,860
 
Operating Income (+$)
Gross Profit132,454,860
Operating Expense-132,002,917
Operating Income38,348,312451,943
 
Operating Expense (+$)
Research Development9,310,827
Selling General Administrative32,645,827
Selling And Marketing Expenses0
Operating Expense132,002,91741,956,654
 
Net Interest Income (+$)
Interest Income3,226,701
Interest Expense-329,510
Other Finance Cost-1
Net Interest Income2,897,190
 
Pretax Income (+$)
Operating Income38,348,312
Net Interest Income2,897,190
Other Non-Operating Income Expenses0
Income Before Tax (EBT)44,597,88238,348,312
EBIT - interestExpense = -329,510
36,722,824
37,052,334
Interest Expense329,510
Earnings Before Interest and Taxes (EBIT)044,927,392
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax44,597,882
Tax Provision-8,036,998
Net Income From Continuing Ops36,560,88436,560,884
Net Income36,722,824
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-2,897,190
 

Technical Analysis of Inbody
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inbody. The general trend of Inbody is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inbody's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of InBody Co.Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 23,000 < 23,150 < 23,150.

The bearish price targets are: 20,850 > 20,700 > 20,462.

Tweet this
InBody Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of InBody Co.Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

InBody Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of InBody Co.Ltd. The current macd is -138.55516666.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Inbody price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Inbody. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Inbody price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
InBody Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartInBody Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of InBody Co.Ltd. The current adx is 17.09.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Inbody shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
InBody Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of InBody Co.Ltd. The current sar is 20,960.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
InBody Co.Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of InBody Co.Ltd. The current rsi is 47.04. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
InBody Co.Ltd Daily Relative Strength Index (RSI) ChartInBody Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of InBody Co.Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Inbody price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
InBody Co.Ltd Daily Stochastic Oscillator ChartInBody Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of InBody Co.Ltd. The current cci is -7.70712909.

InBody Co.Ltd Daily Commodity Channel Index (CCI) ChartInBody Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of InBody Co.Ltd. The current cmo is -5.2873572.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
InBody Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartInBody Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of InBody Co.Ltd. The current willr is -45.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Inbody is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
InBody Co.Ltd Daily Williams %R ChartInBody Co.Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of InBody Co.Ltd.

InBody Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of InBody Co.Ltd. The current atr is 747.07.

InBody Co.Ltd Daily Average True Range (ATR) ChartInBody Co.Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of InBody Co.Ltd. The current obv is 5,843,084.

InBody Co.Ltd Daily On-Balance Volume (OBV) ChartInBody Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of InBody Co.Ltd. The current mfi is 42.77.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
InBody Co.Ltd Daily Money Flow Index (MFI) ChartInBody Co.Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for InBody Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

InBody Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of InBody Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.042
Ma 20Greater thanMa 5022,347.500
Ma 50Greater thanMa 10022,973.000
Ma 100Greater thanMa 20023,410.500
OpenGreater thanClose22,550.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Inbody with someone you think should read this too:
  • Are you bullish or bearish on Inbody? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inbody? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about InBody Co.Ltd

I send you an email if I find something interesting about InBody Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about InBody Co.Ltd.

Receive notifications about InBody Co.Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.